News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Jordi Maeste CEO de Melius organics
#NewAseBioMember | “AseBio is a key platform that brings together the main players in the Spanish biotechnology sector”
Corporate
Meet our new member Melius Organics. We spoke with Jordi Mestre, CEO &…
AseBio - MELIUS ORGANICS
Presentación del Informe AseBio 2024
R&D investment in the biotech sector grows by 5.2% to 1,282 million euros
Healthcare · Agrifood · Industrial biotechnology · Financing
In 2023, the activity of biotech companies in Spain generated more than 13,000 million euros of…
Julio Alonso Babarro, CEO de Airway Shield
#NewAseBioMember | “Being a member of AseBio represents a great opportunity to increase our visibility within the biotechnology sector, both nationally and internationally”
Corporate
Meet our new member Airway Shield. We spoke with Julio Alonso Babarro, CEO.
AseBio - AIRWAY SHIELD
Agustín García-Peiró, CEO y fundador de CIMAB
#NewAseBioMember | “AseBio is a key platform for connecting with other biotech players in Spain”
Corporate
Meet our new member CIMAB. We spoke with Agustín García-Peiró, CEO and Founder.
AseBio - CIMAB
Dr. Carles Domènech, CEO y cofundador de AbilityPharma
AbilityPharma’s IBRILATAZAR (ABTL0812) doubles overall survival in patients with squamous non-small cell lung cancer
Healthcare · Innovative drugs · Advanced therapies
These results support ibrilatazar as a potential backbone therapy for patients with one of the most…
Partners - Ability Pharmaceuticals
Reunión de equipo valorando resultados económicos
Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN-01 in Metastatic Pancreatic Cancer
Healthcare · Access to innovation
Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory…
Partners - THERIVA BIOLOGICS S.L.
BCN HEALTH publica un estudio que pone de relieve los elevados costes sanitarios asociados al carcinoma hepatocelular en España
BCN HEALTH publishes a study highlighting the substantial healthcare costs associated with hepatocellular carcinoma in Spain
Healthcare · Access to innovation
BCN HEALTH has published the study ‘Hepatocellular carcinoma: what are the differential costs…
Partners - BCN Health
N-GENE
Genetics Becomes an Ally for Healthcare Professionals
Healthcare · Access to innovation · Digitalization
Personalized medicine is no longer a promise—it's a reality, with genetics as its key ally. To…
Partners - ADNTRO GENETICS SL
Claudio Hidalgo Cantabrana
#NewAseBioMember | “#NewAseBioMember | “AseBio is the meeting point for all companies that aim to contribute to science through the biotechnology sector””
Healthcare · Corporate
Meet our new member Microviable Therapeutics .  We sponke with Claudio Hidalgo Cantabrana, CEO…
AseBio - MICROVIABLE THERAPEUTICS